Latest Investor Relations News

James Hardie Industries releases its 2026 AGM materials, highlighting a $4.8 billion sales year boosted by AZEK acquisition, board renewals, and a revamped executive pay structure.

BlackRock Investment Management (Australia) has announced the final cash distribution amounts for a broad suite of iShares ETFs, with payments scheduled for 13 July 2026.

Bravura Solutions plans to list on the London Stock Exchange's AIM market by late July 2026, aiming to tap into UK and European institutional investors while maintaining its ASX primary listing.

Matsa Resources has restructured its board and management team, appointing three new non-executive directors with deep technical and commercial expertise to support the expansion and development of its Lake Carey gold asset.

Truscreen Group has issued nearly 150 million new shares at NZ$0.013 each, expanding its share base by 17.4% following a renounceable rights issue. The fully paid shares rank equally with existing stock, lifting total ordinary shares to just over one billion.

Recce Pharmaceuticals secured A$4 million through an institutional placement and launched a Share Purchase Plan to raise up to an additional A$4 million, bolstering funds for commercial licensing and ongoing clinical programs.

Skin Elements Limited has secured a $900,000 placement at a 25% discount to recent prices, bolstering its balance sheet to advance its natural biotechnology product range. The company also appointed Rod Nicholas as non-executive chairman and engaged Phoenix Global Investments for investor relations.

Transurban Group (ASX: TCL) declared a 35-cent unfranked distribution per stapled security for the six months ending 30 June 2026, payable in August with no approvals required.

Galilee Energy has finished construction of the Zydeco-1 drilling site in Louisiana, setting the stage for drilling to commence in early July 2026. The well targets a substantial 13.7 billion cubic feet of gas and 610,000 barrels of condensate, underpinning the company’s US Gulf Coast growth ambitions.

KMD Brands is set to reduce its share count from nearly 1.8 billion to about 72 million through a 1 for 25 consolidation effective early July 2026, simplifying its capital base without changing shareholder value.

Cynata Therapeutics (ASX: CYP) has had its trading suspension lifted immediately following the publication of results from its Phase 3 Osteoarthritis and Phase 2 Graft versus Host Disease clinical trials.

APA Group projects a final distribution of 30.5 cents per security for the six months ending June 2026, marking a modest 1.7% increase over the prior year and maintaining full-year guidance.